[DPHARMA] QoQ Cumulative Quarter Result on 31-Dec-2012 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- 29.96%
YoY- -2.59%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 116,671 75,826 37,837 135,310 99,932 70,412 36,057 118.61%
PBT 31,017 21,963 8,956 35,298 26,298 17,906 8,869 130.22%
Tax -6,842 -4,575 -2,257 -9,284 -6,281 -4,331 -2,161 115.46%
NP 24,175 17,388 6,699 26,014 20,017 13,575 6,708 134.87%
-
NP to SH 24,175 17,388 6,699 26,014 20,017 13,575 6,708 134.87%
-
Tax Rate 22.06% 20.83% 25.20% 26.30% 23.88% 24.19% 24.37% -
Total Cost 92,496 58,438 31,138 109,296 79,915 56,837 29,349 114.80%
-
Net Worth 179,125 187,340 176,143 169,354 167,965 162,400 170,824 3.21%
Dividend
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Div - 5,550 - 19,434 - 4,858 - -
Div Payout % - 31.92% - 74.71% - 35.79% - -
Equity
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Net Worth 179,125 187,340 176,143 169,354 167,965 162,400 170,824 3.21%
NOSH 138,856 138,770 138,695 138,815 138,814 138,803 138,881 -0.01%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin 20.72% 22.93% 17.70% 19.23% 20.03% 19.28% 18.60% -
ROE 13.50% 9.28% 3.80% 15.36% 11.92% 8.36% 3.93% -
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 84.02 54.64 27.28 97.47 71.99 50.73 25.96 118.64%
EPS 17.41 12.53 4.83 18.74 14.42 9.78 4.83 134.90%
DPS 0.00 4.00 0.00 14.00 0.00 3.50 0.00 -
NAPS 1.29 1.35 1.27 1.22 1.21 1.17 1.23 3.22%
Adjusted Per Share Value based on latest NOSH - 138,819
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 12.12 7.88 3.93 14.06 10.38 7.31 3.75 118.44%
EPS 2.51 1.81 0.70 2.70 2.08 1.41 0.70 134.08%
DPS 0.00 0.58 0.00 2.02 0.00 0.50 0.00 -
NAPS 0.1861 0.1946 0.183 0.1759 0.1745 0.1687 0.1775 3.20%
Price Multiplier on Financial Quarter End Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 -
Price 2.55 2.38 2.23 2.13 2.36 2.23 2.40 -
P/RPS 3.03 4.36 8.17 2.19 3.28 4.40 9.24 -52.41%
P/EPS 14.65 18.99 46.17 11.37 16.37 22.80 49.69 -55.66%
EY 6.83 5.26 2.17 8.80 6.11 4.39 2.01 125.85%
DY 0.00 1.68 0.00 6.57 0.00 1.57 0.00 -
P/NAPS 1.98 1.76 1.76 1.75 1.95 1.91 1.95 1.02%
Price Multiplier on Announcement Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 19/11/13 28/08/13 27/05/13 25/02/13 23/11/12 16/08/12 17/05/12 -
Price 2.56 2.44 2.51 2.17 2.28 2.38 2.38 -
P/RPS 3.05 4.47 9.20 2.23 3.17 4.69 9.17 -51.96%
P/EPS 14.70 19.47 51.97 11.58 15.81 24.34 49.28 -55.32%
EY 6.80 5.14 1.92 8.64 6.32 4.11 2.03 123.71%
DY 0.00 1.64 0.00 6.45 0.00 1.47 0.00 -
P/NAPS 1.98 1.81 1.98 1.78 1.88 2.03 1.93 1.71%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment